Nope, this isn’t Groundhog Day, Brock Lesnar has failed a second Usada drug test.
The main draw of UFC 200 was flagged for an out-of-competition anti-doping violation stemming from a test carried out on June 28, a little under two weeks out from his highly-anticipated comeback.
It turns out that Lesnar has also failed an in-competition drug test, as well. The sample in question was taken on July 9, the day of his co-main event fight against knockout monster Mark Hunt.
The UFC confirmed in a press release on Tuesday that Lesnar was popped for the same substance that saw him fail the test on June 28. You can check out the promotion’s full statement below.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
